Zhuhai Rundu Pharmaceutical Co Ltd Class A Cash Flow Conversion Efficiency
Zhuhai Rundu Pharmaceutical Co Ltd Class A cash flow conversion efficiency. Based on the latest financial reports, Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥37.78 Million ≈ $5.53 Million USD) by net assets (CN¥1.05 Billion ≈ $153.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2025)
Cash flow conversion efficiency of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2025. This chart illustrates how Zhuhai Rundu Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Zhuhai Rundu Pharmaceutical Co Ltd Class stock price today for real-time trading data and today's change.
Zhuhai Rundu Pharmaceutical Co Ltd Class A Cash Flow Conversion Ratio Explained
Zhuhai Rundu Pharmaceutical Co Ltd Class A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zhuhai Rundu Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhuhai Rundu Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency. Also see Zhuhai Rundu Pharmaceutical Co Ltd Class market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kolte - Patil Developers Limited
NSE:KOLTEPATIL
|
0.136x |
|
DONGGUAN R.COMMERC. H YC1
F:857
|
N/A |
|
Deep Industries Limited
NSE:DEEPINDS
|
0.009x |
|
Hangzhou Landscape Architecture Design Institute Co Ltd
SHE:300649
|
0.012x |
|
Soft-World International
TWO:5478
|
0.116x |
|
Vital Farms Inc
NASDAQ:VITL
|
-0.096x |
|
Brainsway Ltd
NASDAQ:BWAY
|
0.080x |
|
Magnera Corp placeholder
NYSE:MAGN
|
-0.013x |
Annual Cash Flow Conversion Efficiency for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2025)
The table below shows the annual cash flow conversion efficiency of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2025. Review 002923 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.04 Billion ≈ $151.95 Million |
CN¥104.41 Million ≈ $15.28 Million |
0.101x | -45.15% |
| 2024-12-31 | CN¥1.15 Billion ≈ $168.59 Million |
CN¥211.19 Million ≈ $30.90 Million |
0.183x | +25.17% |
| 2023-12-31 | CN¥1.18 Billion ≈ $172.55 Million |
CN¥172.68 Million ≈ $25.27 Million |
0.146x | +29.73% |
| 2022-12-31 | CN¥1.20 Billion ≈ $175.01 Million |
CN¥135.01 Million ≈ $19.76 Million |
0.113x | -39.03% |
| 2021-12-31 | CN¥1.11 Billion ≈ $162.74 Million |
CN¥205.91 Million ≈ $30.13 Million |
0.185x | -23.22% |
| 2020-12-31 | CN¥1.04 Billion ≈ $151.93 Million |
CN¥250.35 Million ≈ $36.63 Million |
0.241x | +49.86% |
| 2019-12-31 | CN¥940.29 Million ≈ $137.59 Million |
CN¥151.30 Million ≈ $22.14 Million |
0.161x | -11.85% |
| 2018-12-31 | CN¥871.29 Million ≈ $127.50 Million |
CN¥159.04 Million ≈ $23.27 Million |
0.183x | +53.97% |
| 2017-12-31 | CN¥488.84 Million ≈ $71.53 Million |
CN¥57.95 Million ≈ $8.48 Million |
0.119x | -49.82% |
| 2016-12-31 | CN¥398.19 Million ≈ $58.27 Million |
CN¥94.07 Million ≈ $13.77 Million |
0.236x | +46.41% |
| 2015-12-31 | CN¥310.72 Million ≈ $45.47 Million |
CN¥50.14 Million ≈ $7.34 Million |
0.161x | -23.98% |
| 2014-12-31 | CN¥273.31 Million ≈ $39.99 Million |
CN¥58.01 Million ≈ $8.49 Million |
0.212x | +58.34% |
| 2013-12-31 | CN¥236.29 Million ≈ $34.58 Million |
CN¥31.67 Million ≈ $4.63 Million |
0.134x | -61.82% |
| 2012-12-31 | CN¥199.43 Million ≈ $29.18 Million |
CN¥70.01 Million ≈ $10.25 Million |
0.351x | +72.18% |
| 2011-12-31 | CN¥165.33 Million ≈ $24.19 Million |
CN¥33.71 Million ≈ $4.93 Million |
0.204x | -- |
About Zhuhai Rundu Pharmaceutical Co Ltd Class A
Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular, gastrointestinal, antibiotics, analgetic and antipyretics, anti-virus, endocrinology, and respiratory; and pellets for excipient, antiulcerative, diabetes … Read more